Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.63B | 1.69B | 2.09B | 1.89B | 1.39B |
Gross Profit | 733.90M | 730.00M | 864.90M | 825.60M | 550.30M |
EBITDA | 374.50M | 388.50M | 924.80M | 549.40M | 369.60M |
Net Income | 158.50M | 171.00M | 649.30M | 320.80M | 201.60M |
Balance Sheet | |||||
Total Assets | 3.51B | 3.58B | 3.61B | 3.29B | 3.03B |
Cash, Cash Equivalents and Short-Term Investments | 166.80M | 172.50M | 320.60M | 112.80M | 106.50M |
Total Debt | 699.10M | 710.10M | 615.80M | 936.00M | 907.00M |
Total Liabilities | 1.21B | 1.21B | 1.18B | 1.53B | 1.43B |
Stockholders Equity | 2.28B | 2.35B | 2.42B | 1.75B | 1.59B |
Cash Flow | |||||
Free Cash Flow | 137.60M | 156.80M | 160.90M | 190.50M | 166.30M |
Operating Cash Flow | 319.40M | 337.50M | 313.30M | 349.20M | 287.50M |
Investing Cash Flow | -139.10M | -409.80M | 418.10M | -218.40M | -992.40M |
Financing Cash Flow | -182.60M | -52.40M | -550.90M | -111.90M | 722.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | £2.99B | 8.42 | 15.96% | 4.31% | -9.10% | 239.75% | |
66 Neutral | £608.83M | 20.50 | 6.65% | 8.51% | 4.75% | -3.29% | |
64 Neutral | £121.45M | 11.17 | 8.02% | 4.08% | 1.12% | -0.70% | |
62 Neutral | $10.39B | 9.84 | 1.51% | 2.86% | 2.35% | -34.25% | |
62 Neutral | £4.05B | 28.93 | 6.17% | 3.21% | 2.36% | -13.99% | |
59 Neutral | £941.13M | ― | -5.93% | 1.05% | 0.71% | -274.39% | |
52 Neutral | £147.69M | ― | -6.25% | ― | 0.81% | 15.63% |
Croda International Plc announced a transaction involving its Chief Financial Officer, Stephen Richard Oxley, who purchased 3,762 ordinary shares at a price of £26.71 each, totaling £100,483.02. This transaction, disclosed as an initial notification, reflects the company’s ongoing commitment to transparency and may indicate confidence in the company’s future performance, potentially impacting investor sentiment positively.
The most recent analyst rating on (GB:CRDA) stock is a Buy with a £46.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Croda International Plc announced a transaction involving Thomas Herman Riermeier, a member of its Executive Committee, who purchased 1,000 ordinary shares at a price of £26.959 each. This transaction, conducted on July 29, 2025, at the London Stock Exchange, reflects insider confidence in the company’s prospects and could influence stakeholder perceptions positively.
The most recent analyst rating on (GB:CRDA) stock is a Buy with a £46.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Croda International Plc reported a 7% increase in group sales at constant currency for the first half of 2025, driven by higher sales volumes across all its business sectors. Despite a challenging economic environment, the company maintained its full-year outlook and identified additional cost savings, aiming for £100 million in annualized savings by 2027. The strategic focus on operational efficiency and innovation is expected to strengthen Croda’s market position and improve returns, with adjusted operating profit up by 12% at constant currency.
The most recent analyst rating on (GB:CRDA) stock is a Buy with a £46.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Croda International reported a 7% sales growth at constant currency for the first half of 2025, driven by increased volumes across all business sectors, particularly in Beauty Care and Crop Protection. Despite a challenging environment, the company is on track with its strategic plan to enhance earnings and returns, with a focus on cost savings and operational efficiency, aiming for £100m in annualized savings by 2027.
The most recent analyst rating on (GB:CRDA) stock is a Buy with a £46.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Croda International Plc has announced a notification regarding transactions by persons discharging managerial responsibilities (PDMRs) and their closely associated persons. The announcement details the purchase of shares under the Company’s Share Incentive Plan, with shares being purchased and awarded to various executives and committee members. This move is part of Croda’s ongoing efforts to align the interests of its management with those of its shareholders, potentially impacting the company’s market positioning by reinforcing stakeholder confidence.
The most recent analyst rating on (GB:CRDA) stock is a Buy with a £46.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Croda International Plc announced a series of share transactions involving key managerial personnel as part of its Share Incentive Plan. The transactions, conducted on June 10, 2025, involved the purchase of partnership shares, matching shares, and dividend reinvestment shares for several executives, reflecting the company’s ongoing commitment to aligning management interests with shareholder value.
The most recent analyst rating on (GB:CRDA) stock is a Buy with a £46.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Croda International Plc has announced a notification regarding transactions by individuals with managerial responsibilities within the company. The transactions involved the purchase of ordinary shares by Thomas Michael Brophy, the Company Secretary, and Sarah Elizabeth Brophy, a person closely associated with him. The purchases were conducted on May 29, 2025, at a price of £30.697651 per share, with varying volumes. This disclosure highlights transparency in the company’s operations and adherence to regulatory requirements, potentially impacting stakeholder confidence.
The most recent analyst rating on (GB:CRDA) stock is a Buy with a £46.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Croda International Plc announced a transaction involving Mrs. Sandra Elaine Breene, a member of its Executive Committee. The transaction involved the reinvestment of dividends into ordinary shares, with a total aggregated volume of 5 shares at a price of £154.00. This notification highlights the company’s ongoing efforts to maintain transparency in its financial dealings and may impact stakeholder perceptions regarding executive management’s commitment to the company’s growth.
The most recent analyst rating on (GB:CRDA) stock is a Buy with a £46.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Croda International Plc has announced the purchase of shares under the Company’s Share Incentive Plan by the SIP Trustee, MUFG Corporate Markets Trustees (Nominees) Ltd. The transaction involves the acquisition of partnership shares and the awarding of matching shares to persons discharging managerial responsibilities (PDMRs) within the company, reflecting a strategic move to align management interests with shareholder value.
The most recent analyst rating on (GB:CRDA) stock is a Buy with a £46.00 price target. To see the full list of analyst forecasts on Croda International stock, see the GB:CRDA Stock Forecast page.
Croda International Plc announced a transaction involving the purchase of 1,000 ordinary shares by Ian Alan Bull, a Non-Executive Director. This transaction, conducted on May 6, 2025, at the London Stock Exchange, reflects a financial commitment to the company, potentially signaling confidence in its market position and future prospects.